These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27452162)

  • 1. Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy.
    Kolseth IB; Reine TM; Parker K; Sudworth A; Witczak BJ; Jenssen TG; Kolset SO
    J Diabetes Complications; 2017 Jan; 31(1):245-252. PubMed ID: 27452162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amyloid A enrichment impairs the anti-inflammatory ability of HDL from diabetic nephropathy patients.
    Mao JY; Sun JT; Yang K; Shen WF; Lu L; Zhang RY; Tong X; Liu Y
    J Diabetes Complications; 2017 Oct; 31(10):1538-1543. PubMed ID: 28760652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between markers of endothelial dysfunction and early signs of renal dysfunction in pediatric obesity and type 1 diabetes.
    Marcovecchio ML; de Giorgis T; Di Giovanni I; Chiavaroli V; Chiarelli F; Mohn A
    Pediatr Diabetes; 2017 Jun; 18(4):283-289. PubMed ID: 27246625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purple corn anthocyanins inhibit diabetes-associated glomerular monocyte activation and macrophage infiltration.
    Kang MK; Li J; Kim JL; Gong JH; Kwak SN; Park JH; Lee JY; Lim SS; Kang YH
    Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1060-9. PubMed ID: 22791342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
    Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
    Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
    Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
    Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble urokinase plasminogen activator receptor in type 1 diabetic children, relation to vascular complications.
    Sherif EM; El Maksood AAA; Youssef OI; Salah El-Din NY; Khater OKM
    J Diabetes Complications; 2019 Sep; 33(9):628-633. PubMed ID: 31301955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory Effects of the Nutraceutical Garlic Derivative Allicin in the Progression of Diabetic Nephropathy.
    Arellano Buendía AS; Tostado González M; Sánchez Reyes O; García Arroyo FE; Argüello García R; Tapia E; Sánchez Lozada LG; Osorio Alonso H
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway.
    Jia Z; Nallasamy P; Liu D; Shah H; Li JZ; Chitrakar R; Si H; McCormick J; Zhu H; Zhen W; Li Y
    J Nutr Biochem; 2015 Mar; 26(3):293-302. PubMed ID: 25577468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell cytokine production and endothelial dysfunction in type 2 diabetic patients with nephropathy.
    Kamel L; Morsy A; El Shamaa A
    East Mediterr Health J; 2009; 15(4):807-16. PubMed ID: 20187532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
    Petrica L; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Vlad D; Popescu R; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Jianu DC
    J Diabetes Complications; 2015 Mar; 29(2):230-7. PubMed ID: 25511877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of IL-20 in chronic kidney disease and diabetic nephropathy: Pathogenic and therapeutic implications.
    Chang MS; Hsu YH
    J Leukoc Biol; 2018 Nov; 104(5):919-923. PubMed ID: 29999545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial.
    Mafi A; Namazi G; Soleimani A; Bahmani F; Aghadavod E; Asemi Z
    Food Funct; 2018 Sep; 9(9):4763-4770. PubMed ID: 30113051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium dobesilate may alleviate diabetes‑induced endothelial dysfunction and inflammation.
    Zhou Y; Yuan J; Qi C; Shao X; Mou S; Ni Z
    Mol Med Rep; 2017 Dec; 16(6):8635-8642. PubMed ID: 29039485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy.
    Fernández-Juárez G; Villacorta Perez J; Luño Fernández JL; Martinez-Martinez E; Cachofeiro V; Barrio Lucia V; Tato Ribera AM; Mendez Abreu A; Cordon A; Oliva Dominguez JA; Praga Terente M
    Nephrology (Carlton); 2017 May; 22(5):354-360. PubMed ID: 27003829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased indoleamine 2,3-dioxygenase activity in type 2 diabetic nephropathy.
    Zhang Y; Ruan Y; Zhang P; Wang L
    J Diabetes Complications; 2017 Jan; 31(1):223-227. PubMed ID: 27646613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of endothelial dysfunction and inflammation predict progression of diabetic nephropathy in African Americans with type 1 diabetes.
    Roy MS; Janal MN; Crosby J; Donnelly R
    Kidney Int; 2015 Feb; 87(2):427-33. PubMed ID: 24918153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.